Doctor Yuan Chunhao is a Lecturer/Master supervisor from the School of Chemical and Pharmaceutical Engineering, Shandong First Medical University (Shandong Academy of Medical Sciences). She received her Ph.D. from the China Agricultural University in 2017. She presided over the "Development of metal-catalyzed asymmetric cycloaddition Reactions Involving alkenyl cyclobutane, alkenyl azacyclobutane and alkenyl oxacyclobutane" project sponsored by the National Natural Science Foundation of China, and the "Study of [3+n] cycloaddition reactions involving positive ions of Azaoxyallyl" joint project sponsored by Natural Science Foundation of Shandong Province. She is the first or corresponding author in various papers published in Organic Letters, Advanced Synthesis & Catalysis, Ecotoxicology and Environmental Safety, Organic & Biomolecular Chemistry, RSC Advances, and ChemistrySelect journals. She has published 9 SCI papers and applied for one invention patent as the first author. Her research direction is as follows:
1. Creation of new heterocyclic drugs
2. Cyclic addition and cyclization of in situ zwitterions catalyzed by organic and metal catalysts
3. Research on the creation and mechanism of nano-drugs
Doctor Yuan Chunhao is a Lecturer/Master supervisor from the School of Chemical and Pharmaceutical Engineering, Shandong First Medical University (Shandong Academy of Medical Sciences). She received her Ph.D. from the China Agricultural University in 2017. She presided over the "Development of metal-catalyzed asymmetric cycloaddition Reactions Involving alkenyl cyclobutane, alkenyl azacyclobutane and alkenyl oxacyclobutane" project sponsored by the National Natural Science Foundation of China, and the "Study of [3+n] cycloaddition reactions involving positive ions of Azaoxyallyl" joint project sponsored by Natural Science Foundation of Shandong Province. She is the first or corresponding author in various papers published in Organic Letters, Advanced Synthesis & Catalysis, Ecotoxicology and Environmental Safety, Organic & Biomolecular Chemistry, RSC Advances, and ChemistrySelect journals. She has published 9 SCI papers and applied for one invention patent as the first author. Her research direction is as follows:
1. Creation of new heterocyclic drugs
2. Cyclic addition and cyclization of in situ zwitterions catalyzed by organic and metal catalysts
3. Research on the creation and mechanism of nano-drugs